Semliki Forest virus (SFV) normally causes an acute lethal encephalitis in mice following intranasal inoculation. However, animals co-administered with 10 LDso SFV and defective interfering (DI) SFV survive the infection without clinical signs of disease. In this report we demonstrate the isolation of infectious virus from the brains of 12/169 protected mice up to 6-5 months post-infection. Although, with one exception, mice were clinically normal, five of 12 of the SFV isolates were identical to the original virus as judged by plaque morphology, maximum temperature for growth, virulence in mice and pathology. Others were less virulent (although not any were plaque or temperature-sensitive mutants) and on re-inoculation into fresh mice caused a demyelinating pathology which was not an attribute of the original inoculum. How the virulent virus can persist in brain, sometimes in amounts in excess of 100 LDso, without causing disease remains to be determined.
Persistence of Virulent Semliki Forest Virus in Mouse Brain Following
Co-inoculation with Defective Interfering Particles Semliki Forest virus (SFV) normally causes an acute lethal encephalitis in mice following intranasal inoculation. However, animals co-administered with 10 LDso SFV and defective interfering (DI) SFV survive the infection without clinical signs of disease. In this report we demonstrate the isolation of infectious virus from the brains of 12/169 protected mice up to 6-5 months post-infection. Although, with one exception, mice were clinically normal, five of 12 of the SFV isolates were identical to the original virus as judged by plaque morphology, maximum temperature for growth, virulence in mice and pathology. Others were less virulent (although not any were plaque or temperature-sensitive mutants) and on re-inoculation into fresh mice caused a demyelinating pathology which was not an attribute of the original inoculum. How the virulent virus can persist in brain, sometimes in amounts in excess of 100 LDso, without causing disease remains to be determined.
Defective interfering (DI) virus particles are produced during the replication of many, possibly all, animal viruses (Huang & Baltimore, 1977; Perrault, t 981 ) and characteristically have a genome which contains deletions, often of most of the standard (infectious) virus genome. This deletion means that DI virus can only replicate in cells co-infected with standard virus. Such co-infection usually results in the propagation of DI virus at the expense of standard virus, hence the phenomenon of interference Huang & Baltimore, 1977; Perrault, 1981) .
The possibility that DI particles could exert effects on virus infections in vivo was first postulated by Huang & Baltimore (1970) who suggested that DI particles may modulate both acute and persistent virus infections. Since then a large literature has accumulated showing that in cultured cells DI particles modulate acute virus infections and are involved in the establishment and/or maintenance of persistent infections Perrault, 1981) including infection with Semliki Forest virus (SFV) (Stark & Kennedy, 1978) . However, there have been relatively few reports on the effects of DI viruses on acute infections of animals (Barrett & Dimmock, 1984a, b, c; Barrett et al., 1984b; Crouch et al., 1982; Dimmock & Kennedy, 1978; Doyle & Holland, 1973; Fultz et al., 1982a; Mims, 1956; Popescu & Lehmann-Grube, 1977; Rabinowitz et al., 1977; Rabinowitz & Huprikar, 1979; Spandidos & Graham, 1976; von Magnus, 1951 ; Welsh et al., 1977) and much of the earlier work is difficult to interpret as it lacked controls to exclude immunogenic effects of DI virus. The involvement of DI viruses in persistent infections of animals has not been established with any certainty.
Viruses vary greatly in their ability to form persistent infections. At one end of the spectrum, persistence is established by the herpesviruses as a normal part of their life-cycle. At the opposite extreme, SFV does not become persistent in a vertebrate host unless it is immunodeficient * Mice were inoculated by the intranasal route as described by Dimmock & Kennedy (1978) with DI SFV at 2 h before infection and together with 10 LDs0 (6000 p.f.u.) SFV.
t DI SFV p4 and p 13 denote that DI virus was prepared by four or 13 undiluted passages of standard virus in BHK-21 cells (Barrett et al., 1984b) . No mice survived inoculation with 10 LDs0 plus u.v.-irradiated SFV (u.v. SFV contained the same amount of SFV antigen as D1 SFV and was inoculated in parallel with DI SFV to control the immunogenic load administered). Brains were removed from mice, homogenized and resuspended in 4 ml GMEM containing 2~ calf serum. Samples were plaque-assayed for infectivity on monolayers of CEF cells (Barrett et al., 1981 ; Morser et al., 1973) . Mock-infected mice and mice inoculated only with DI virus were also sampled at each time point; no virus was recovered. Another control group received 8 × 104 p.f.u, avirulent SFV [derived from strain A774 (Bradish et al., I971) ] as shown.
:~ Number of mice with detectable virus in brain/number of mice sampled. Mice scored as negative contained < 10 p.f.u./brain. § One mouse with conjunctivitis of the right eye was killed on day 196. The right eye plus optic nerve (R), left eye plus optic nerve (L) and brain were assayed separately for virus. The latter was negative. No virus was found in optic tissue of p4-treated mice sampled at 257 days post-infection.
(athymic nude mice: Jagelman et al., 1978; Bradish et al., 1979) or has undergone passive immunotherapy (Seamer et al., 1971) . Thus, SFV provides a system to test for the possible effects of DI virus on the establishment of persistence in vivo.
Intranasal inoculation of mice with SFV (ts ÷ strain; Tan et al., 1969) results in an encephalitis and death at 5 days post-infection. Co-inoculation of such mice with 10 LDso SFV + DI SFV results in a silent encephalitis in the majority of animals with no sign of infection (i.e. protection) but if the DI SFV is replaced by non-infectious virus antigen there is no alteration of the lethal infection (Barrett & Dimmock, 1984b; Barrett et al., 1984 b; Dimmock & Kennedy, 1978) . DI SFV-protected mice usually clear infectious virus by 7 days (Barrett et al., 1984b) . The immune response of mice to infections modulated by different DI SFV preparations varies and protected mice can be either resistant (e.g. DI SFV pl3a) or susceptible (e.g, DI virus p4) to challenge with 100 LD50 at 3 weeks post-infection (Barrett & Dimmock, 1984b) . Since protection (by DI SFV p4) was not due to an adaptive immune response (Barrett & Dimmock, 1984b) or to interferon (Barrett & Dimmock, 1986) we have concluded that it is a property of the DI virus itself.
To determine whether treatment with DI virus prevented the elimination of infectious virus from the mouse, a total of 169 random-bred male mice, 5 weeks old (CFLP, Hacking and Churchill Ltd, Wyton, Huntingdon, U.K.) were co-inoculated (Dimmock & Kennedy, 1978) with 10 LD5o plus either DI virus p4 or p13 (stock 13a; Barrett & Dimmock, 1984b) and their brains were titrated directly for infectivity by plaque assay (Table 1) .
Virus was isolated from a total of ten of 84 (12 ~) mice treated with DI virus p4 and two of 85 (2.4 ~) mice treated with DI virus p 13. The greater number of isolations from the former group may correlate with their weaker adaptive immune response (Barrett et al., 1984b) . With only one exception, all of the sampled mice appeared clinically normal. One mouse (196/4/1) developed an infection of the right eye at 186 days which closely resembled that often observed at day 4 post-infection of an acute SFV infection. Virus was recovered from extracts of each eye together with its optic nerve; however, virus was not detectable in the brain. The number of persistently infected mice decreased with time after inoculation and virus was isolated from only one of 33 mice sampled between 168 and 257 days post-infection. Thus, infectious virus could be isolated reproducibly but at low frequency from mice co-inoculated with l0 LDs0 + DI virus p4, an infection which results normally in the production of no neutralizing antibody, no inflammatory response and weak protective immunity. Further, no histopathological lesions or virus antigen were detected in the brains of these protected mice (Barrett & Dimmock, 1984b; Barrett et al., 1984b; Crouch et al., 1982) . These experimental observations contrast with those obtained following co-inoculation of hamsters with DI vesicular stomatitis virus (VSV) where virus was only detected following co-cultivation. Surviving hamsters had high titres of VSV-neutralizing antibodies, no evidence of immunosuppression, and positive histopathological lesions; also, virus antigen was detected in several different tissues (Fultz et al., 1982b (Fultz et al., , 1984 .
Since the LDso of the ts ÷ strain of SFV is the same as the IDs0 (Barrett et al., 1984b) it was not possible to set up a sub-lethal infection to control the results described above. As an alternative, mice were inoculated in parallel with avirulent SFV [derived from strain A774 (Bradish et al., 1971) ] which results in an encephalitis with only transient signs of malaise and complete recovery by day 10 post-infection. No virus was detected in the brains of 54 mice (< 1.9~) sampled between 12 and 257 days post-infection. Thus, persistence of infectious virus was found only in non-lethal infections produced by the administration of DI virus.
Brains containing detectable virus had infectivity titres varying from 1.2 x 101 to 8.0 x 104 p.f.u./brain, suggesting that the extent of infectious virus multiplication varied between persistently infected mice. DI virus was not detected in the brains by either of two in vitro interference assays which measured inhibition of virus RNA synthesis (Barrett et al., 1981) or of the yield of infectious progeny virus (Barrett et al., 1984a) . Preliminary attempts to increase the detection of infectious virus by undiluted passage and co-cultivation were unsuccessful.
Viruses isolated from persistently infected animals were identified as SFV as they were all neutralized to the same extent by specific anti-SFV rabbit polyclonal antibody. The isolates had plaquing characteristics in chick embryo fibroblasts (CEF) cells similar to ts ÷ SFV over a range of temperatures, with the ratio of titres at 33 °C :37 °C being within fourfold and no plaquing by either the original SFV or the isolates at 39 °C. Plaque size and morphology of isolates did not differ from that of the inoculum virus (data not shown).
Virulence of viruses isolated from persistently infected mice was measured in terms of p.f.u./LDso and kinetics of killing (Table 2) . Virus was passaged in cell culture no more than twice to increase the titre to at least 3 x 104 p.f.u./ml, the equivalent of 1 LDso of the original inoculum (ts ÷ virus). Isolates showed a range of p.f.u./LDs0 values, with eight of 12 being within threefold of the parental strain (102.8 p.f.u./LDs0 ) or of virus isolates from infected mice at 7 days after infection. The mean times of death of mice inoculated with the isolates fell into two groups: those which had the same pattern of disease as with SFV ts ÷ (death at 4.9 + 0.07 days post-infection) and those which died at 8 to 9 days post-infection. The slower disease did not necessarily correlate with a high p.f.u./LDso, e.g. isolate 12/4/2 had 103'1 p.f.u./LDs0. In all, five of 12 isolates were as virulent as ts ÷, three were considered avirulent by both criteria and three possessed only one of the avirulence characteristics. There was no correlation between the time after the original infection that virus was isolated from persistently infected mice and either criterion of virulence. While SFV underwent genetic change towards avirulence during persistent infection of some mice, others, notably 89/4/1, retained virulence on both counts. Virus isolates from the right or left eyes at 196 days were avirulent by this assessment.
The pathology caused by representative isolates [virulent, 14/13/1, 21/4/2, 89/4/2; of intermediate virulence, 12/4/2, 12/4/3; avirulent, 12/13/1, 196/4/1 (R)] was investigated by infecting mice with 10 LDs0 by the intranasal route. Sections of brain and spinal cord were examined for histopathology after staining with haematoxylin and eosin or immunohisto- 2.5 4.7 8.9 + 0.42 * 7/4/1 is virus isolated on day 7 from a mouse treated with DI SFV p4 and is sample number 1. Viruses isolated from days 12 to 196 are from Table l. All isolates contained < 1 LDs0/20 gl; therefore, all (including ts +) were passaged once in BHK-21 cells at 0.05 p.f.u./cell for 40 h at 33 °C to obtain titres of 107 to 109 p.f.u./ml.
5. These were isolated by picking 50 to 100 plaques from CEF monolayers. Virus was eluted, pooled and then passaged once in BHK-21 cells as described above. The extra passage in chick cells did not change the virulence of the isolate, as shown by samples isolated at 21 days post-infection directly on BHK cells or by initially picking plaques from CEF monolayers. Time of death and p.f.u./LDs0 were determined by intranasal inoculation. chemistry with a convalescent rabbit antiserum to SFV, together with an enzyme-linked biotinstreptavidin method (Amersham). Data should be viewed in the light of the characteristic pathology caused by a known avirulent strain (Crouch et al., 1982) . Virulent SFV, although fatal by 5 days, causes relatively few observable changes in the central nervous system and little cellular infiltration whereas the avirulent SFV exhibits an extensive pathology with considerable glial involvement, demyelination and cellular infiltration.
Isolates from persistently infected mice which had been designated as virulent (Table 2) showed characteristic pathology at 4 days post-infection although the extent of histopathological lesions varied considerably. Cortical degeneration was present in mice infected with virulent isolates but was rarely observed in those mice inoculated with avirulent virus or virus of intermediate virulence. However, ablation of pyramidal cells of the hippocampus was pronounced in groups infected with either virulent or avirulent isolates. A distinct difference between these two groups was that the latter had spinal cord lesions. In these mice, at 9 days there was a severe glial reaction accompanied by focal demyelination and there was also focal demyelination in brain. This was only seen with one virulent isolate (14/13/1) at 4 days postinfection.
In immunohistochemical tests the majority of mice (16/20) showed the presence of antigen. The most pronounced staining was in those infected with the virulent isolates 14/13/1 and 21/4/2, which all showed pronounced cellular necrobiosis and hippocampal lesions in the pyramidal cell layer. On the other hand, mice infected with avirulent isolates and which had lesions of similar severity and location contained far less antigen. Conversely, other mice with no lesions or only moderate changes nevertheless contained distinctly stained antigen. Of particular note were the spinal cords of mice infected with avirulent strains, which had severe histopathological lesions but no detectable antigen. It is clear that focal demyelination did not correlate with demonstration of antigen but that changes affecting the pyramidal cell layer of the hippocampus were invariably accompanied by the presence of antigen.
Thus, histo-and immunopathological examinations show that some isolates from persistently infected mice retained the characteristics of the virulent inoculum virus in all respects examined while at the other extreme there were avirulent mutants with the ability to cause focal demyelinating lesions.
Our results therefore demonstrate that DI virus can modulate a potentially lethal virus infection and cause it to become persistent. Although the proportion of virus isolations diminished with time, 27~ of mice treated with DI SFV p4 yield virus at 21 days post-infection. This we consider significant as mice inoculated with infectious SFV alone died at 4.9 days and no virus was found in mice infected with avirulent SFV after 11 days.
The relatively low level of persistence may be due to an unfavourable ratio of DI : standard virus being administered, to virus being present in a form which is not amenable to isolation, or to host variation. However, as mentioned earlier, SFV does not normally become persistent in its vertebrate hosts. Attempts are now underway to investigate the mechanisms of persistence and we already know that mice protected by DI SFV have no detectable inflammatory response, histopathology or virus antigen in brain on days 4 and 11 post-infection (Barrett et at., 1984b; Crouch et al., 1982) and this suggests that extensive virus replication does not take place. It is quite possible that virus is restricted to certain locations in the brain in the same way that at day 196 virus was isolated from the eye but not from the brain, How persistence is maintained is unknown but it must involve a mechanism which restricts the spread of potentially lethal virus, especially as the highest titres isolated were equivalent to over 100 LD~0 and yet the mice were apparently healthy. Protected mice (169 in total) were observed for up to 9 months after infection and all but one remained clinically normal. The only other reports of persistent infections with SFV in vertebrate hosts were obtained when the immunological status of the animal had been altered either by prior passive immunization (Seamer et al., 1971) or by using athymic nude mice (Jagelman et al., 1978; Bradish et al., 1979) . However, as the persistent infections which we have found were established in immunologically normal mice we conclude that they result directly from the inoculation of DI virus. Nonetheless, the establishment of persistence may be concerned with malfunction of the immune response as the majority of mice surviving virulent SFV infection by administration of DI SFV p4 lacked neutralizing antibody and all failed to establish protective immunity (Barrett & Dimmock, 1984b; and unpublished data) . This presumptive immunosuppression might arise in a variety of ways but the most likely is direct interaction with lymphocytes as demonstrated with measles virus (Casali et al., 1984) or by the selection of genetic variants as seen with lymphocytic choriomeningitis virus (Ahmed et al., 1984) . A search for the presence of viral genome sequences in mouse tissue using molecular probes will provide valuable information to help solve this interesting problem.
In conclusion, this report fully vindicates the prediction of Huang & Baltimore (1970) that DI virus can change the expression of a virus disease in vivo. Two aspects merit further investigation. First, we should like to know how a virus which was previously known only to cause an acute and lethal disease can become persistent without losing virulence. Second, we should like to test the hypothesis that, if the subclinical persistent infection by avirulent SFV variants was broken (for example, by immunosuppression), they would give rise to demyelinating disease. The value of this system is that it provides a model for understanding how modulation of acute virus infections takes place in nature.
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